eSpCas9(1.1)-T2A-Puro Citations (4)
Originally described in: eSpCas9(1.1)-T2A-PuroUnpublished
Articles Citing eSpCas9(1.1)-T2A-Puro
Articles |
---|
Recharacterization of the mammalian cytosolic type 2 (R)-beta-hydroxybutyrate dehydrogenase as 4-oxo-l-proline reductase (EC 1.1.1.104). Kwiatkowski S, Bozko M, Zarod M, Witecka A, Kocdemir K, Jagielski AK, Drozak J. J Biol Chem. 2022 Mar;298(3):101708. doi: 10.1016/j.jbc.2022.101708. Epub 2022 Feb 10. PubMed |
Mapping of the regions implicated in nuclear localization of multi-functional DNA repair endonuclease XPF-ERCC1. Akahori R, Takamori C, Wakasugi M, Matsunaga T. Genes Cells. 2022 May;27(5):356-367. doi: 10.1111/gtc.12932. Epub 2022 Mar 8. PubMed |
Sequential and directional insulation by conserved CTCF sites underlies the Hox timer in stembryos. Rekaik H, Lopez-Delisle L, Hintermann A, Mascrez B, Bochaton C, Mayran A, Duboule D. Nat Genet. 2023 Jul;55(7):1164-1175. doi: 10.1038/s41588-023-01426-7. Epub 2023 Jun 15. PubMed |
Sirtuin 5-mediated deacetylation of TAZ at K54 promotes melanoma development. Kim G, Bhattarai PY, Lim SC, Lee KY, Choi HS. Cell Oncol (Dordr). 2023 Dec 19. doi: 10.1007/s13402-023-00910-w. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.